CoChat
Sign Up
Cited by 13

Defining Radiation Treatment Interruption Rates During the COVID-19 Pandemic: Findings From an Academic Center in an Underserved Urban Setting

Gaudio, Elizabeth, Ammar, Nariman, Gunturkun, Fatma, Akkus, Cem, Brakefield, Whitney, Wakefield, Daniel V., Pisu, Maria, Davis, Robert +2 more·2023·International Journal of Radiation Oncology*Biology*Physics
DOI 10.1016/j.ijrobp.2022.09.073PMC PMC9584778
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijrobp.2022.09.073

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 50

  1. [1]Ferrer RA Acevedo AM Agurs-Collins TD COVID-19 and social distancing efforts-implications for cancer control JAMA Oncol 7 2021 503 504 33331856
  2. [2]Jazieh AR Akbulut H Curigliano G Impact of the COVID-19 pandemic on cancer care: A global collaborative study JCO Global Oncol 6 2020 1428-1338 PMC7529504 32986516
  3. [3]Kaufman HW Chen Z Niles J Changes in the number of us patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic JAMA Netw Open 3 2020 e2017267 PMC7403918 32749465
  4. [4]Patt D Gordan L Diaz M Impact of COVID-19 on cancer care: How the pandemic is delaying cancer diagnosis and treatment for American seniors JCO Clin Cancer Inform 4 2020 1059 1071 33253013 PMC7713534
  5. [5]DeGroff A Miller J Sharma K COVID-19 impact on screening test volume through the national breast and cervical cancer early detection program, January-June 2020, in the United States Prev Med 151 2021 106559 PMC9026719 34217410
  6. [6]Lai AG Pasea L Banerjee A Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: Near real-time data on cancer care, cancer deaths and a population-based cohort study BMJ Open 10 2020 e043828 PMC7674020 33203640
  7. [7]Wakefield DV Carnell M Dove APH Location as destiny: Identifying geospatial disparities in radiation treatment interruption by neighborhood, race, and insurance Int J Radiat Oncol Biol Phys 107 2020 815 826 32234552 PMC13440333
  8. [8]Bese NS Hendry J Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation Int J Radiat Oncol Biol Phys 68 2007 654 661 17467926
  9. [9]Giddings A. Treatment interruptions in radiation therapy for head-and-neck cancer: Rates and causes J Med Imaging Radiat Sci 41 2010 222 229 31051883
  10. [10]Matsuo K Machida H Ragab OM Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer J Surg Oncol 116 2017 482 491 28543055 PMC7523389
  11. [11]Urjeet A Patel MOP Holloway N Rosen F. Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer Laryngoscope 119 2009 538-533 19160390
  12. [12]Petereit DG Sarkaria JN Chappell R The adverse effect of treatment prolongation in cervical carcinoma Int J Radiat Oncol Biol Phys 32 1995 1301 1307 7635769
  13. [13]Leticia M Nogueira LS Efstathiou JA. Association between declared hurricane disasters and survival of patients with lung cancer undergoing radiation treatment JAMA Netw Open 322 2019 269 271 PMC6635902 31310288
  14. [14]Khalil AA Bentzen SM Bernier J Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas Int J Radiat Oncol Biol Phys 55 2003 568 575 12573743
  15. [15]Ohri N Rapkin BD Guha C Radiation therapy noncompliance and clinical outcomes in an urban academic cancer center Int J Radiat Oncol Biol Phys 95 2016 563 570 27020104
  16. [16]Cox JD Pajak TF Asbell S Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: Analysis of 1244 cases from 3 radiation therapy oncology group (RTOG) trials Int J Radiat Oncol Biol Phys 27 1993 493 498 8226140
  17. [17]Thomas K Martin T Gao A Interruptions of head and neck radiotherapy across insured and indigent patient populations J Oncol Pract 13 2017 e319 e328 28267393
  18. [19]Wakefield DV Sanders T Wilson E Initial impact and operational responses to the COVID-19 pandemic by American radiation oncology practices Int J Radiat Oncol Biol Phys 108 2020 356 361 32890512 PMC7462779
  19. [20]Lee S Heo J. Covid-19 pandemic: A new cause of unplanned interruption of radiotherapy in breast cancer patients Med Oncol 39 2021 5 34739633 PMC8569493
  20. [21]Ying X Bi J Ding Y Management and outcomes of patients with radiotherapy interruption during the COVID-19 pandemic Front Oncol 11 2021 754838 PMC8639682 34868962
  21. [22]Alterio D Volpe S Marvaso G Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy Head Neck 42 2020 1482 1490 32557972 PMC7323327
  22. [23]Tramacere F Asabella AN Portaluri M Impact of the COVID-19 pandemic on radiotherapy supply Radiol Res Pract 2021 2021 5550536 PMC8118736 34035961
  23. [24]Venkatasai J John C Kondavetti SS Impact of COVID-19 pandemic on patterns of care and outcome of head and neck cancer: Real-world experience from a tertiary care cancer center in India JCO Glob Oncol 8 2022 e2100339 PMC8887950 35213235
  24. [28]Hibbert JD Liese AD Lawson A Evaluating geographic imputation approaches for ZIP code level data: An application to a study of pediatric diabetes Int J Health Geogr 8 2009 54 19814809 PMC2763852
  25. [31]Decker KM Lambert P Feely A Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba Curr Oncol 28 2021 3081 3090 34436035 PMC8395519
  26. [33]Spencer K Jones CM Girdler R The impact of the COVID-19 pandemic on radiotherapy services in England, UK: A population-based study Lancet Oncol 22 2021 309 320 33493433 PMC7825861
  27. [34]Riera R Bagattini AM Pacheco RL Delays and disruptions in cancer health care due to COVID-19 pandemic: Systematic review JCO Glob Oncol 7 2021 311 323 33617304 PMC8081532
  28. [35]Papautsky EL Hamlish T. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic Breast Cancer Res Treat 184 2020 249 254 32772225 PMC7415197
  29. [36]Chen RC Haynes K Du S Association of cancer screening deficit in the United States with the COVID-19 pandemic JAMA Oncol 7 2021 878 884 33914015 PMC8085759
  30. [37]Eskander A Li Q Hallet J Access to cancer surgery in a universal health care system during the COVID-19 pandemic JAMA Netw Open 4 2021 e211104 PMC7953273 33704472
  31. [38]Lamont EB Diamond SS Katriel RG Trends in oncology clinical trials launched before and during the COVID-19 pandemic JAMA Netw Open 4 2021 e2036353 PMC7841452 33502481
  32. [39]McBain RK Cantor JH Jena AB Decline and rebound in routine cancer screening rates during the COVID-19 pandemic J Gen Intern Med 36 2021 1829 1831 33742300 PMC7978463
  33. [40]Maringe C Spicer J Morris M The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: A national, population-based, modelling study Lancet Oncol 21 2020 1023 1034 32702310 PMC7417808
  34. [41]Hanna TP King WD Thibodeau S Mortality due to cancer treatment delay: Systematic review and meta-analysis BMJ 371 2020 m4087 33148535 PMC7610021
  35. [42]Balogun OD Bea VJ Phillips E. Disparities in cancer outcomes due to COVID-19: A tale of 2 cities JAMA Oncol 6 2020 1531 1532 32789508
  36. [43]Wang Q Berger NA Xu R. Analyses of risk, racial disparity, and outcomes among us patients with cancer and COVID-19 infection JAMA Oncol 7 2021 220 227 33300956 PMC7729584
  37. [44]Fu J Reid SA French B Racial disparities in COVID-19 outcomes among black and white patients with cancer JAMA Netw Open 5 2022 e224304 PMC8961318 35344045
  38. [45]Cheng E Soulos PR Irwin ML Neighborhood and individual socioeconomic disadvantage and survival among patients with nonmetastatic common cancers JAMA Netw Open 4 2021 e2139593 PMC8683967 34919133
  39. [46]Kantamneni N. The impact of the COVID-19 pandemic on marginalized populations in the United States: A research agenda J Vocat Behav 119 2020 103439 PMC7205696 32390658
  40. [49]Sharpless N. Q&A: Ned Sharpless on COVID-19 and cancer prevention Cancer Prev Res (Phila) 14 2021 615 618 33910912
  41. [50]Decker KM Lambert P Feely A Evaluating the impact of the COVID-19 pandemic on new cancer diagnoses and oncology care in Manitoba Curr Oncol 28 2021 3081 3090 34436035 PMC8395519
  42. [51]Wakefield DV Eichler T Wilson E Variable impact of the COVID-19 pandemic on U.S. radiation oncology practices Int J Radiat Oncol Biol Phys 113 2022 14 20 35122927 PMC8810273
  43. [52]Portaluri M Barba MC Musio D Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities Radiother Oncol 150 2020 191 194 32621832 PMC7329675
  44. [53]Gupta A Ohri N Haffty BG. Hypofractionated radiation treatment in the management of breast cancer Expert Rev Anticancer Ther 18 2018 793 803 29902386 PMC6312641
  45. [54]Murray Brunt A Haviland JS Wheatley DA Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial Lancet 395 2020 1613 1626 32580883 PMC7262592
  46. [55]Roy S Morgan SC. Hypofractionated radiotherapy for localized prostate cancer: When and for whom? Curr Urol Rep 20 2019 53 31359187
  47. [56]Konski AA. Defining value in radiation oncology: Approaches to weighing benefits vs costs Oncology (Williston Park) 31 2017 248 254 28412775
  48. [57]Shaverdian N Gillespie EF Cha E Impact of telemedicine on patient satisfaction and perceptions of care quality in radiation oncology J Natl Compr Canc Netw 19 2021 1174 1180 33395627 PMC8254817
  49. [58]Franco I Perni S Wiley S Equity in radiation oncology post-COVID: Bridging the telemedicine gap Int J Radiat Oncol Biol Phys 108 2020 479 482 32890538 PMC7462878
  50. [59]Jazieh AR Chan SL Curigliano G Delivering cancer care during the COVID-19 pandemic: Recommendations and lessons learned from ASCO global webinars JCO Glob Oncol 6 2020 1461 1471 32997537 PMC7529523

Cited by

Sorted by citations

Authors
Gaudio, E., Ammar, N., Gunturkun, F., Akkus, C., Brakefield, W., Wakefield, D. V., Pisu, M., Davis, R., Shaban-Nejad, A., & Schwartz, D. L.
Venue
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier BV
Published
2023-06
Volume
116
Issue
2
Pages
379-393
ISSN
0360-3016
DOI
10.1016/j.ijrobp.2022.09.073
PMC
PMC9584778
Cited by
13
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review